Lifelong Aortic Stenosis Management: Life Beyond The First Procedure
Published: 20 April 2022
A new interactive format where you play a pivotal role in solving complex cases.
Radcliffe Cardiology – in association with Edwards Lifesciences and Antares Interactive Digital – is delighted to present this innovative educational broadcast In the context of lifetime management.
Bringing together a faculty of international standing, this interactive event aims to best illustrate the challenges encountered and treatment strategies available to interventional cardiologists and the wider Heart Team in the management of the condition.
Delivered in two distinct sections, part one will address selecting the first mode of intervention according to the latest ESC/EACTS Guidelines; the second part will focus on post-TAVI follow-up assessing the potential need for reintervention.
The broadcast has been carefully curated to position audience opinion and interaction at its core – attendees are invited to explore these pertinent topics through reviewing two intriguing and complex cases posted on the broadcast’s Interactive Case Explorer. The Case Explorer has been split into 2 parts, Part 1: TAVI vs. SAVR and Part 2: Post TAVI follow-up, each Explorer referring to each part of the broadcast. These will form the basis for expert panel discussion and analysis.
Chair Dr Victoria Delgado (Barcelona, ES) will be joined by Prof Martine Gilard (Brest, FR), Prof Jan-Malte Sinning (Cologne, DE), Dr Radoslaw Parma (Silesia, PL), Prof Philippe Pibarot (Québec, CA), Prof Anne Bernard (Tours, FR) and Prof David Wood (Vancouver, CA) for what promises to be a truly unique best-in-class virtual broadcast.
- Learn how the latest ESC/EACTS Guidelines are implemented within the Heart Team’s practice.
- Identify the most important factors when considering the mode of first intervention for aortic stenosis in the context of lifetime management and the updated 2021 ESC/EACTS Guidelines.
- Understand how echo-derived aortic gradients may affect clinical decision during post-TAVI follow-up.
- Learn about the role of echo-derived aortic gradients in monitoring valve performance.
- Interventional Cardiologists
- General Cardiologists
- Cardiac Surgeons
More from this programme
ESC/EACTS VHD 2022 Guidelines: Learning From a Contemporary Case
Dr David Wood works as an interventional cardiologist at Vancouver General Hospital.
Dr Wood is a professor in the Department of Medicine at the University of British Columbia and a co-founding member of the Centre for Heart Valve Innovation in Vancouver.
He serves as the President of the Canadian Association of Interventional Cardiology.
Victoria Delgado is a cardiologist specializing in non-invasive imaging.
In 2010 she graduated cum laude on the topic “Novel cardiac imaging technologies.” In 2005, she completed training as a cardiologist and in 2006 her interest in non-invasive imaging. Both programs she attended at the Hospital Clinic, associated with the University of Barcelona, Spain.
In 2007 she began a fellowship in “new non-invasive cardiac imaging” at the Cardiology Department at the Leiden University Medical Center. Since 2010 she has been a staff member at the Department of Cardiology of the LUMC
Cardiologist, Echocardiographer, specialist in Interventional echocardiography
Cardiologist, Echocardiographer, specialist in Interventional echocardiography, Head of the EchoLab, Tours University Hospital, Expertise in Valvular Heart Disease and Cardiovascular Imaging, Head of the Simulation Training center MEDISIM Tours, University of Tours
Board member of the Société Française de Cardiology (SFC), President-elect of the Filiale d’Imagerie Cardiovasculaire (SFC), Board member of the European Association of Cardiovascular Imaging Women Task Force
Director of the Research Group in Valvular Heart Diseases
Philippe Pibarot is Full Professor at the Department of Medicine of Laval University, Canada. He also serves as Director of the Research Group in Valvular Heart Diseases at the Quebec Heart and Lung Institute. He received his doctorate from the University Claude Bernard, France, and his PhD in biomedical sciences from the University of Montreal, Canada. Dr Pibarot has been the recipient of numerous awards including the Annual Achievement Award of the Canadian Society of Echocardiography, and the Research Achievement Award of the Canadian Cardiovascular Society. His key interests include valvular heart diseases, cardiovascular surgery, heart valve diseases, and pulmonary hypertension.